Sarah Cannon Research Institute Scri Oncology Partners

Clinical research site in Brandywine, Maryland

As of July 2026, 1 paid clinical trial is recruiting at Sarah Cannon Research Institute Scri Oncology Partners in Brandywine, Maryland. Active studies at this site focus on CRC (Colorectal Cancer) alongside other indications. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 19, 2026.

Recruiting clinical trials at Sarah Cannon Research Institute Scri Oncology Partners (1)

A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer

for CRC (Colorectal Cancer)

67 locations incl. Tucson

Sponsor: Incyte Corporation

Sex: All·Age: 18+

Code: NCT07284849·Phase 3·Recruiting·Listed Dec 2025

Apply to this trial

More research sites in Brandywine

Maryland Oncology Hematology, P.A. (3 trials)
Maryland Oncology Hematology - Brandywine (1 trial)
Maryland Oncology Hematology, PA (1 trial)

Explore more

Paid clinical trials in Brandywine, MD · Maryland clinical trials